Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
| Publicado en: | Breast Cancer Research Vol. 15; no. 2; pp. 1 - 16 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
BioMed Central
2013
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=90260319&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 90260319 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 14655411 8UYJ jtl: Breast Cancer Research issn: 14655411 maglogo: N pubinfo: dt: 2013 vid: 15 iid: 2 pid: 24147 pub: BioMed Central artinfo: ui: 90260319 10.1186/bcr3460 90260319 ppf: 1 ppct: 15 formats: fmt: @attributes: type: P tig: atl: Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. aug: au: Borges, Sahra Döppler, Heike Perez, Edith A. Andorfe, Cathy A. Zhifu Sun Anastasiadis, Panos Z. Aubrey Thompson, E. Geiger, Xochiquetzal J. Stor, Peter affil: Department of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL 32224, USA sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|